We're Not Audacious On Audentes Therapeutics' IPO
July 18, 2016 at 18:14 PM EDT
Audentes plans to raise $75 million through its upcoming IPO, set to price this Tues. evening, 7.19. We recommend that investors wait to see if the company's product candidates are approved for clinical trials before buying shares.
